Could ketamine and therapy curb suicidal thoughts in Tough-to-Treat patients?
NCT ID NCT07569198
First seen May 07, 2026 · Last updated May 14, 2026 · Updated 1 time
Summary
This study looks at whether a drug called ketamine, given through an IV, along with a type of talk therapy (DBT), can help reduce suicidal thoughts in people with borderline personality disorder and depression or bipolar disorder. About 120 adults will get either ketamine or a placebo, plus therapy, and be followed for 9 months. The goal is to see if this combination works faster and better than therapy alone.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MAJOR DEPRESSIVE DISORDER (MDD are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.